Literature DB >> 7249879

Bleeding after liver biopsy does not correlate with indices of peripheral coagulation.

K Ewe.   

Abstract

Contraindications for percutaneous liver biopsy are often derived arbitrarily from coagulation status of peripheral blood, but no objective data are available on the duration of bleeding from the site of liver biopsy. "Liver bleeding time" (LBT) was measured after liver biopsy had been performed at laparoscopy in 200 consecutive patients using a 1.8-mm-diameter Menghini needle. LBT was then analyzed in relation to prothrombin time, platelet count, whole blood clot time, length of biopsy cylinder, and liver histopathology. There was no correlation among any of these variables. The average LBT was 4 min 37 sec +/- 3 min 48 sec (SD). In 10 patients LBT was prolonged over 12 min (mean +/- 2 SD), but their clotting indices were not different from those of other patients. Bleeding could be stopped easily by compression if necessary. This lack of correlation may be explained by the high concentration of clotting factors in hepatic parenchyma and by mechanical compression of the needle track by the elastic tissue in the liver. It is concluded that indices of coagulation in the peripheral blood used in this study are unreliable guides of the risk of bleeding after liver biopsy and, hence, are of limited value in determining contraindications to this procedure.

Entities:  

Mesh:

Year:  1981        PMID: 7249879     DOI: 10.1007/bf01313579

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  5 in total

1.  [ON ADVANTAGES AND DANGERS OF THE MENGHINI METHOD OF LIVER BIOPSY].

Authors:  H THALER
Journal:  Wien Klin Wochenschr       Date:  1964-07-17       Impact factor: 1.704

2.  Risks of needle biopsy of the liver.

Authors:  R TERRY
Journal:  Br Med J       Date:  1952-05-24

3.  Liver biopsy and prognosis in acute liver failure.

Authors:  J Scotto; P Opolon; J Etévé; D Vergoz; M Thomas; J Caroli
Journal:  Gut       Date:  1973-12       Impact factor: 23.059

4.  [Histological changes in severe hepatitis and their outcome. Apropos of 45 cases followed up by biopsy].

Authors:  P Paliard; F Patricot; J A Grimaud
Journal:  Ann Gastroenterol Hepatol (Paris)       Date:  1972 Mar-Apr

5.  [Limitations and hazards of percutaneous liver biopsy with the Menghini needle. Experiences with 80,000 liver biopsies].

Authors:  H Lindner
Journal:  Dtsch Med Wochenschr       Date:  1967-09-29       Impact factor: 0.628

  5 in total
  60 in total

1.  Percutaneous liver biopsy: what is the current approach? Results of a questionnaire survey.

Authors:  W Mayoral; J H Lewis
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

2.  Guidelines on the use of liver biopsy in clinical practice. British Society of Gastroenterology.

Authors:  A Grant; J Neuberger
Journal:  Gut       Date:  1999-10       Impact factor: 23.059

3.  The risk of postpolypectomy bleeding during colonoscopy in patients with early liver cirrhosis.

Authors:  Jung Won Jeon; Hyun Phil Shin; Joung Il Lee; Kwang Ro Joo; Kwan Mi Pack; Jae Myung Cha; Jae Jun Park; Jun Uk Lim; Kyuseong Lim
Journal:  Surg Endosc       Date:  2012-05-31       Impact factor: 4.584

4.  Severe prolongation of the INR in spur cell anemia of cirrhosis: true-true and related?

Authors:  Vinay Sundaram; Abdullah M S Al-Osaimi; Jason J Lewis; Ton Lisman; Stephen H Caldwell
Journal:  Dig Dis Sci       Date:  2006-07       Impact factor: 3.199

Review 5.  New insights into the coagulopathy of liver disease and liver transplantation.

Authors:  M Senzolo; P Burra; E Cholongitas; A-K Burroughs
Journal:  World J Gastroenterol       Date:  2006-12-28       Impact factor: 5.742

6.  Liver biopsy:complications and risk factors.

Authors:  Pornpen Thampanitchawong; Teerha Piratvisuth
Journal:  World J Gastroenterol       Date:  1999-08       Impact factor: 5.742

Review 7.  [Coagulation management in patients with liver disease].

Authors:  A Bienholz; A Canbay; F H Saner
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-05-05       Impact factor: 0.840

8.  4 Plasma for Therapeutic Use.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

9.  Severe thrombocytopenia in a child secondary to passive platelet antibody transfer from a plasma transfusion.

Authors:  Chelsea L Collins; J Paul Scott; Julie A Panepinto; Rowena C Punzalan
Journal:  J Pediatr Hematol Oncol       Date:  2013-07       Impact factor: 1.289

10.  An audit of fresh frozen plasma usage and effect of fresh frozen plasma on the pre-transfusion international normalized ratio.

Authors:  S A Shinagare; N N Angarkar; S R Desai; M R Naniwadekar
Journal:  Asian J Transfus Sci       Date:  2010-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.